All In Biotech

Drug Trial Radar · NCT00567255

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects

A Multicenter, Randomized, Double Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion Sustained Release (SR) and Placebo in Obese Subjects

Last checked: Nov 19, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,496 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,496

Actual

Start

Dec 2007

Primary completion

Jun 2009

Study completion Jun 2009

Sponsor

Lead sponsor
Orexigen Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Dec 4, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether the combination of naltrexone SR and bupropion SR is safe and effective in the treatment of obesity.

Conditions

  • Obesity
  • Overweight

Interventions

  • Naltrexone SR 32 mg/bupropion SR 360 mg/dayDrug

  • PlaceboDrug

  • Ancillary therapyBehavioral

    Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-primary: Body Weight- Mean Percent Change From Baseline to Week 28Time frame: Baseline, 28 weeks
  2. Co-primary: Body Weight- Proportion of Subjects With ≥5% Decrease From Baseline to Week 28Time frame: Baseline, 28 weeks

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Lovelace Scientific Resources

    Phoenix, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

  • HealthStar Research

    Hot Springs, Arkansas

  • Northern California Research

    Carmichael, California

  • Sierra Medical Research

    Fresno, California

  • Pharmacology Research Institute

    Newport Beach, California

  • Center for Human Nutrition University of Colorado Health Sciences Center

    Denver, Colorado

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • George Washington University

    Washington D.C., District of Columbia

  • Suncoast Clinical Research

    Palm Harbor, Florida

  • Comprehensive NeuroScience, Inc

    Atlanta, Georgia

  • Clinical Research Atlanta

    Stockbridge, Georgia

  • Northwest Indiana Center for Clinical Research

    Valparaiso, Indiana

  • Trover Center for Clinical Studies

    Madisonville, Kentucky

  • Nutrition and Weight Mangement Center Boston Medical Center

    Boston, Massachusetts

  • Milford Emergency Associates, Inc

    Milford, Massachusetts

  • Summit Research Network, Inc.

    Okemos, Michigan

  • Twin Cities Clinical Research

    Brooklyn Center, Minnesota

  • Mercy Health Research

    St Louis, Missouri

  • Radiant Research, Inc.

    St Louis, Missouri

  • Clinical Research Center of Nevada

    Las Vegas, Nevada

  • Endocrinology & Diabetes Consultants

    Dover, New Hampshire

  • Lovelace Scientific Resources

    Albuquerque, New Mexico

  • Central New York Clinical Research

    Manlius, New York

  • Comprehensive Weight Control Program

    New York, New York

  • Behavioral Medical Research

    Staten Island, New York

  • Metrolina Medical Research

    Charlotte, North Carolina

  • Patient Priority

    Cincinnati, Ohio

  • Wells Institute For Health Awareness

    Kettering, Ohio

  • The Portland Clinic

    Portland, Oregon

  • Geisinger Medical Center

    Danville, Pennsylvania

  • Mountain View Clinical Research

    Greer, South Carolina

  • Palmetto Medical Research

    Mt. Pleasant, South Carolina

  • Clinical Research Associates, Inc.

    Nashville, Tennessee

  • The Cooper Institute

    Dallas, Texas

  • Summit Research Network, Inc.

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.